If You Used Talcum Powder and Were Diagnosed With Ovarian Cancer, This Is What You Need to Know Right Now
You are reading this because you or someone you love used talcum powder — Johnson’s Baby Powder, Shower to Shower, Cashmere Bouquet, or another talc-based product — for years, maybe decades, and then the diagnosis came. Ovarian cancer. Or mesothelioma. And nobody ever told you the powder you trusted on your body every day might have been carrying asbestos straight to your ovaries.
You may not have connected the two. Most women don’t — not for years, sometimes not until after they read about the lawsuits or heard a news report. The cancer shows up decades after the exposure, and doctors rarely ask about talcum powder use when taking a history. That gap between exposure and diagnosis is not your failure. It is the design of a disease that hides, and it is the design of a company that stayed silent while it hid.
What we can tell you is this: you are not alone, you are not imagining it, and the law has a path. More than 68,435 women have filed claims in the federal multidistrict litigation against Johnson & Johnson and other talc manufacturers. Courts have awarded over $2.51 billion to women who used these products and developed ovarian cancer. A former FDA Commissioner testified under oath that J&J found asbestos in its talc in the 1970s and submitted altered test results to regulators. A federal judge in January 2026 ruled that the scientific evidence linking genital talc use to ovarian cancer is reliable enough for a jury to hear.
The question now is not whether the harm was real. The question is whether your claim is still alive, whether the evidence that proves your case still exists, and whether you act before the clock runs out. That is what this page is for. We are going to walk you through every piece of it — the science, the corporate record, the deadlines, the money, the evidence that is dying while you read this, and the steps that move the clock from working against you to working for you.
What Is the Talcum Powder Ovarian Cancer Litigation?
The talcum powder ovarian cancer litigation is a nationwide mass tort consolidated as MDL-2738 in the U.S. District Court for the District of New Jersey. More than 68,435 claims are pending as of mid-2026, and the number grows every year — up 9,375 cases from the prior year alone. The plaintiffs are women who allege that long-term use of talc-based body powders for feminine hygiene caused them to develop ovarian cancer, mesothelioma, or other serious cancers, and that the manufacturers knew about the risk for decades and sold the products without warning anyone.
Johnson & Johnson is the primary defendant. Its products — Johnson’s Baby Powder and Shower to Shower — were marketed for decades as safe, gentle, and trusted enough for babies. Other defendants include Imerys Talc America (the talc mining supplier), Colgate-Palmolive (maker of Cashmere Bouquet), Avon Products (maker of Skin So Soft Satin Talc), and Whittaker, Clark & Daniels (a talc distributor). Each of these companies is alleged to have played a role in putting asbestos-contaminated talc into products that women applied directly to their bodies.
The MDL is not a class action. Each woman keeps her own individual claim. The consolidation just means that all pretrial proceedings — discovery, expert challenges, bellwether trials — happen in one federal court before one judge, so the shared questions of science and corporate conduct get answered once instead of 68,000 times. After pretrial work is complete, individual cases may settle or be sent back to their home districts for trial. If you or a loved one was diagnosed with ovarian cancer after using talc-based products, you may also be eligible to pursue compensation. The first step is a free case review to determine whether your history fits the criteria.
How Does Talc Cause Ovarian Cancer?
Talc is a soft mineral mined from the earth. It forms in geological proximity to asbestos — the two minerals are neighbors underground, and contamination during mining and processing is not an accident. It is a feature of where talc comes from. Even trace amounts of asbestos in talc are known to cause serious illness, including mesothelioma and ovarian cancer.
When a woman applies talcum powder to the genital area, the particles do not simply sit on the skin. Talc particles are small enough to travel through the reproductive tract — upward through the vagina, through the cervix, through the uterus, and into the fallopian tubes and ovaries. Scientists have identified talc particles in ovarian tumors during scientific examinations. The mechanism is chronic inflammation: the particles lodge in ovarian tissue, the body cannot clear them, and the sustained inflammatory response over years and decades can drive abnormal cell growth that becomes cancer.
The asbestos contamination makes this worse. Asbestos fibers are sharp, durable, and biopersistent — the body cannot break them down. When asbestos-contaminated talc reaches the ovaries, the fibers sit there for decades, causing the kind of chronic inflammation and cellular damage that the International Agency for Research on Cancer — the world’s leading cancer authority — has recognized as a confirmed cause of ovarian cancer. IARC classifies asbestos as a Group 1 confirmed human carcinogen and specifically identifies it as a cause of ovarian cancer.
The science is not fringe. A January 2026 federal court ruling admitted expert testimony on the link between genital talcum powder use and ovarian cancer, finding that the experts used reliable scientific methods to support their opinions. This was a critical Daubert gatekeeping decision — it means the defense can no longer argue that the science is too uncertain for a jury to hear. The jury will hear it.
The latency is the cruelest part. Studies have found that women who regularly use talcum powder in the genital area have a 33% increased risk of ovarian cancer, according to the National Library of Medicine. But the disease forms slowly — often decades after exposure begins. A woman who used baby powder daily in her twenties may not be diagnosed until her fifties or sixties. By then, the cancer is frequently at an advanced stage because the symptoms are vague and easy to overlook: bloating, pelvic discomfort, changes in bowel habits, feeling full quickly, fatigue, back pain. There is no unique set of ovarian cancer symptoms that only occur when talcum powder is the cause — it presents the same way regardless of the trigger. Many women are not diagnosed until the cancer has already spread.
What Johnson & Johnson Knew — and When They Knew It
The core of the talcum powder litigation is not that the company made a product that turned out to be dangerous. It is that the company knew the product was dangerous, knew it was contaminated with asbestos, and made a deliberate decision to keep selling it without a warning.
Evidence presented in court shows that from at least 1971 to the early 2000s, Johnson & Johnson’s raw talc and manufactured powders sometimes tested positive for asbestos, according to internal company records. In May 2026, the former head of the FDA — David Kessler — testified in an ovarian cancer lawsuit that J&J found asbestos fibers in their talc products in the 1970s but covered up the findings by providing the agency with altered test results.
“It’s my position that every time a scientist found chrysotile or tremolite [asbestos], your company descended on that scientist, right, and tried to explain that away. That I think is the story of the last 50 years.”
— Former FDA Commissioner David Kessler, testifying in talc litigation, May 2026
This is the pattern the lawsuits describe: scientists inside and outside the company found asbestos in the talc. Each time, the company’s response was not to recall the product, not to warn consumers, not to reformulate — but to challenge the scientist, explain away the finding, and keep selling. Internal J&J documents already produced through MDL discovery establish this pattern dating back to the 1970s.
The company’s own marketing tells the other side of the story. Johnson’s Baby Powder was advertised as safe enough for infants. Shower to Shower was marketed specifically for feminine hygiene, with slogans encouraging daily use. Women who used these products for decades were following the instructions on the label and trusting the brand on the bottle. The failure to warn shifts the responsibility entirely to the manufacturer — a woman who used talc for feminine hygiene was doing what the product was designed and marketed for, not taking an unforeseeable risk.
The Regulatory Gap That Let This Happen
One of the reasons this danger persisted for so long is a gap in federal law that most consumers never know about. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act, which prohibits adulterated cosmetics containing harmful substances including asbestos — but does not require pre-market safety testing or FDA approval for cosmetic products. A company can put a cosmetic powder on the shelf without the FDA ever reviewing its safety, testing its ingredients, or confirming it is free of contamination.
Talcum powder fell into this gap. It was classified as a cosmetic. No one at the FDA was required to test it before it reached consumers. The only testing that happened was the testing the manufacturers chose to do — and when that testing revealed asbestos, the companies controlled whether and how the results reached the public. The January 2026 federal court ruling admitting expert testimony is especially significant because it means the scientific evidence has cleared the Daubert reliability standard — the gatekeeping test that determines whether a jury is allowed to hear expert opinions at all. Without that ruling, the science could have been locked out of the courtroom. With it, the defense’s ability to challenge general causation is substantially weakened.
The Defendants and the Corporate Shell Game
Johnson & Johnson is the primary defendant, but it is not the only one, and understanding who you are actually suing matters more than most people realize.
Johnson & Johnson designed, manufactured, marketed, and sold Johnson’s Baby Powder and Shower to Shower for decades. The company is accused of altering FDA test results, suppressing scientific findings, and engaging in a coordinated campaign to discredit scientists who found asbestos in talc. J&J discontinued talc-based baby powder in the U.S. and Canada — but only after the litigation was well underway, and after decades of sales to women who were never warned.
The company has also engaged in what critics call the “Texas two-step” — a corporate restructuring maneuver designed to push talc liabilities into a subsidiary entity and then file that entity for bankruptcy, attempting to force a global settlement through the bankruptcy court rather than fighting each case in the tort system. J&J attempted this three times:
- 2021: First Texas two-step bankruptcy attempt, shifting talc liabilities to a subsidiary.
- 2023: Federal courts blocked both of J&J’s first two bankruptcy attempts, ruling the company was not in financial distress.
- 2024: J&J’s subsidiary (Red River Talc LLC) filed for bankruptcy a third time, offering an $8 billion settlement.
- 2025: A U.S. bankruptcy judge rejected the proposed $8 billion settlement, citing concerns about the amount being insufficient and problems with the voting process.
Three times the company tried to wall these cases off inside a bankruptcy it created on purpose. Three times a court threw it out. The cases are back in the regular court system, where they belong. J&J has reportedly set aside $11 billion to resolve all talc lawsuits — a figure that tells you the company’s own accountants understand the scale of the liability.
The other defendants matter too. Imerys Talc America was the talc mining and processing supplier to J&J — the source of the raw talc entering the consumer product supply chain. Colgate-Palmolive manufactured Cashmere Bouquet talc-based body, face, and dusting powders. Avon Products marketed talc-based cosmetic products that tested positive for asbestos. Whittaker, Clark & Daniels distributed asbestos-contaminated talc into the manufacturing chain. Each of these companies played a role, and each can be a separate source of accountability.
Products identified in the litigation as containing asbestos-contaminated talc include Johnson’s Baby Powder, Shower to Shower, Cashmere Bouquet, Avon Skin So Soft Satin Talc, Chanel No. 5 Body Powder, Gold Bond Medicated Powder, and Mennen Baby Powder, among others. If you regularly used any of these products and later developed ovarian cancer, your use history is the foundation of a potential claim.
The Legal Theories: How These Cases Are Won
The talcum powder litigation rests on several distinct legal theories, each attacking a different aspect of the manufacturers’ conduct:
Failure to warn is the core theory. The manufacturers knew for over 50 years that their talc products could contain asbestos and that genital talc use was linked to ovarian cancer. They marketed the products as safe anyway, without any warning to consumers. The December 2025 California bellwether verdict found J&J liable for failure to warn. This theory is powerful because the duty to warn is a manufacturer’s most basic obligation — when you know your product can cause cancer, you tell the people buying it.
Design defect argues that talc-based products were unreasonably dangerous due to asbestos contamination during mining and processing, and that safer alternatives were feasible. Cornstarch-based powders existed and were available. The product’s design risk outweighed its utility because there was a safer way to make the same product. This theory attacks the decision to keep using talc when a safe substitute was available.
Negligence claims that the manufacturers breached their duty of reasonable care by testing for asbestos, discovering contamination, and continuing to sell the products without implementing safeguards or warnings. They knew, they measured, they found the danger — and they shipped it anyway.
Fraud and misrepresentation goes further: J&J allegedly altered test results submitted to the FDA, publicly denied asbestos contamination despite internal evidence, and engaged in a coordinated campaign to discredit scientists who found asbestos in talc. This theory supports both compensatory and punitive damages. The Missouri appellate court that upheld the $2.12 billion verdict found J&J’s actions showed “significant reprehensibility” and that the company had “disregarded the safety of consumers” in pursuit of profit.
Conspiracy alleges a coordinated effort between J&J and talc suppliers to suppress scientific findings and influence regulatory oversight. A Missouri jury found J&J liable for conspiracy in a wrongful death case.
False representation covers the marketing and advertising of talc products as safe for feminine hygiene use despite internal knowledge of cancer risk. The December 2025 California jury found J&J liable for false representation.
Notable Verdicts and Settlements — With Their Full Status
Every verdict below carries its complete procedural history because a headline number stripped of what happened to it on appeal is misleading, not powerful.
$2.12 Billion Missouri Verdict (22 women) — In July 2018, a Missouri jury awarded $4.69 billion to 22 women who developed ovarian cancer linked to J&J baby powder. The Missouri Court of Appeals reduced the award to approximately $2.12 billion in June 2020. The Missouri Supreme Court denied review in November 2020. The U.S. Supreme Court denied certiorari in June 2021. This reduced award stands as affirmed. The appeals court said the evidence showed that J&J had “disregarded the safety of consumers” in pursuit of profit and that the company’s actions showed “significant reprehensibility.” This is the largest ovarian cancer talcum powder verdict to date and the cite-safe headline number.
$40 Million California Bellwether Verdict (December 2025) — A California jury awarded $40 million to two longtime J&J talc users diagnosed with ovarian cancer, allocating $22 million to one plaintiff and $18 million to the other. The jury found J&J liable for negligence, failure to warn, and false representation, though it declined to award punitive damages. This was a bellwether trial — a test case whose outcome is closely watched because it shapes settlement negotiations and case valuations for the thousands of remaining claims. The appellate status of this verdict has not yet been confirmed.
$700 Million Multi-State Settlement (2024) — J&J agreed to pay $700 million to settle claims from 42 states and Washington, D.C., that the company misled consumers about the safety of its talc-based baby powder. As part of the settlement, the company admitted no wrongdoing.
$110 Million Missouri Verdict (2017) — A Missouri jury ordered J&J to pay more than $110 million to a 62-year-old woman who developed ovarian cancer after using the company’s talc-based powders for four decades. The verdict included $5.4 million in compensatory damages and $105 million in punitive damages.
$100 Million Settlement (2020) — J&J agreed to pay over $100 million to resolve more than 1,000 talc lawsuits alleging that baby powder was contaminated with asbestos and caused ovarian cancer and mesothelioma. This was the first large global settlement of its kind for the company, with individual payouts averaging approximately $100,000, though amounts varied based on individual circumstances.
$72 Million Wrongful Death Verdict (2016) — A Missouri jury ordered J&J to pay $72 million to the family of an Alabama woman who used J&J’s baby powder and Shower to Shower for feminine hygiene for more than 35 years, was diagnosed with ovarian cancer in 2013, and passed away in 2016 at age 62. The jury awarded $10 million in actual damages and $62 million in punitive damages after finding the company liable for fraud, negligence, and conspiracy. This was the first U.S. jury award in a talc ovarian cancer case.
$70 Million California Verdict (2016) — A St. Louis jury awarded more than $70 million to a California woman who developed ovarian cancer after decades of using J&J’s baby powder.
Federal courts have ordered both sides into court-supervised mediation, pushing toward a potential negotiated global settlement. J&J’s reported $11 billion reserve signals that the company’s own financial team understands the exposure. But a settlement is not guaranteed, and individual cases continue to be tried.
What Your Case May Be Worth
The value of a talcum powder ovarian cancer case depends on the specific facts of your situation — how long you used the products, which products you used, your age at diagnosis, the stage and type of your cancer, your treatment history, and the law of your state. No lawyer can promise a specific number, and any firm that quotes you a figure before reviewing your medical records and exposure history is not being honest with you.
What we can tell you is what the landscape looks like. The case value range in this litigation spans from approximately $100,000 on the low end — reflecting the 2020 global settlement average across roughly 1,000 cases — to over $50 million on the high end, driven by individual trial verdicts that included substantial punitive damages. The wide range reflects the difference between participating in a global settlement, where J&J’s $11 billion reserve and court-ordered mediation suggest per-claimant values in the low-to-mid six figures for most claimants, and taking a case to trial, where the value is driven by punitive damages, venue, and case-specific factors.
Economic damages include medical treatment costs that can exceed $200,000 a year, according to the American Journal of Obstetrics and Gynecology. These costs encompass surgery (removal of the ovaries, fallopian tubes, uterus, and nearby tissue where cancer may have spread), chemotherapy, immunotherapy, targeted therapy, and hormone therapy. They also include lost wages, diminished earning capacity, and future medical care needs.
Non-economic damages cover physical pain and suffering, emotional distress, loss of quality of life, and the psychological trauma of a cancer diagnosis attributable to decades of unknowing exposure to a trusted consumer product. The December 2025 California verdict allocated $22 million and $18 million to two plaintiffs, predominantly in compensatory categories — a window into how juries value these human losses.
Punitive damages have been the dominant driver of the largest talc verdicts. The $2.12 billion Missouri verdict included massive punitive awards based on the appellate court’s finding of “significant reprehensibility” and J&J’s disregard for consumer safety. The $110 million individual verdict included $105 million in punitives. Punitive damages punish the company for its conduct and send a message that profiting from concealment will cost more than the concealment saved.
Wrongful death claims carry additional damage categories: the decedent’s pre-death pain and suffering, loss of consortium, funeral expenses, and loss of financial support. If your loved one passed away from ovarian cancer linked to talcum powder use, you may be able to file a wrongful death claim on their behalf. The $72 million wrongful death verdict demonstrates the potential of these claims.
Past results depend on the facts of each case and do not guarantee future outcomes.
The Evidence Clock — What Exists and How Fast It Disappears
This is the section that decides whether your case lives or dies. The proof of a talcum powder ovarian cancer claim is built from several categories of evidence, and each one is on a clock. Some of those clocks are already running against you.
Talc product samples and packaging. Physical containers of Johnson’s Baby Powder, Shower to Shower, Cashmere Bouquet, or Avon products can be tested for asbestos fiber content to establish specific product contamination and support causation. Packaging identifies lot numbers and manufacturing dates. But J&J discontinued U.S. talc sales, making matching product samples increasingly scarce. Family members may discard old cosmetics during household cleanouts without realizing they are discarding evidence. If you still have old talc product containers — any brand, any vintage — keep them. Do not throw them away. Store them in a sealed bag and tell your attorney.
Medical and pathology records. These establish your ovarian cancer diagnosis, histological type, and stage. Tumor tissue can potentially be tested for talc and asbestos fiber presence to support specific causation. Hospital pathology retention policies vary — some institutions purge slides after 7 to 10 years unless specifically requested. If your diagnosis was years ago, your pathology slides may already be at risk. Request them now, before routine destruction schedules thin them.
Purchase receipts, store loyalty records, and subscription data. These corroborate the duration, frequency, and specific brands of talc product use — central to exposure quantification and product identification. Retailer transaction records are routinely purged on 3-to-7-year retention cycles. Digital loyalty data may persist longer, but access requires timely preservation requests. This is why the preservation letter goes out the day you call, not after months of deliberation.
Witness statements from family members and friends. These establish long-term genital talc use patterns and product preferences, particularly when purchase receipts are unavailable. Witness memories fade over time. Elderly family witnesses may become unavailable due to illness or death — particularly in wrongful death cases, where the person who would best confirm the decedent’s product use is the decedent herself. Identify and document witness recollections early.
Internal J&J corporate documents. Decades of testing records, internal communications about asbestos findings, and marketing strategies have been largely produced through MDL discovery. These documents are the backbone of the failure-to-warn and fraud theories. Additional documents may exist in individual defendants’ files. Corporate document retention policies may eliminate records not subject to existing litigation holds. Former employees with knowledge may retire or become unavailable.
FDA correspondence and regulatory submission records. Former FDA Commissioner Kessler’s testimony about J&J submitting altered test results means regulatory filings may contain discrepancies between submitted and actual test data. Federal regulatory records are generally preserved under NARA schedules, but private communications and internal agency deliberations may have limited accessibility.
The single fastest-dying category of evidence is the physical product and the witness memory. If you are reading this page and you have old talc containers in a bathroom cabinet or a storage closet, or if your mother or sister used these products and you remember which brands sat on the shelf — that information is worth more right now than it will be in six months. Every month that passes, the proof gets thinner.
The Defense Playbook — What J&J’s Lawyers Will Do and How We Answer
Johnson & Johnson has some of the most sophisticated defense lawyers in the world. They have been fighting these cases for over 15 years, and they have a playbook. Here are the moves you should expect, and the counter to each one.
Play 1: “The plaintiff cannot prove which specific product she used or for how long.” Product identification is the defense’s favorite battleground. They will argue that without receipts or physical containers, you cannot prove you used J&J’s product as opposed to a competitor’s. The counter is witness testimony — family members, friends, and your own documented history of product preferences — corroborated by marketing history (J&J’s market dominance in baby powder means most women who used talc used J&J) and by the absence of warnings on any talc product. The product identification does not have to be perfect. It has to be more likely than not.
Play 2: “The cancer was caused by something else — genetics, BRCA mutations, family history, hormone therapy, or idiopathic factors.” The defense will bring in experts to argue your ovarian cancer had an alternative cause. The counter is a thorough alternative-causation workup including genetic testing and family cancer history, combined with the exposure evidence showing decades of genital talc use. The IARC classification of asbestos as a confirmed cause of ovarian cancer and the January 2026 expert-admissibility ruling make it harder for the defense to exclude the talc causation theory entirely.
Play 3: “Too much time has passed between the exposure and the diagnosis.” The defense will emphasize the decades-long gap between talc use and cancer diagnosis to argue causation is speculative. The counter is the science: latency is a feature of asbestos-related and talc-related disease, not evidence against it. The long gap is exactly what the medical literature predicts. And the discovery rule — discussed below — means the legal clock starts when you connected the illness to its cause, not when you were exposed.
Play 4: “The FDA never required a warning, so we complied with all regulations.” The defense will argue regulatory compliance equals safety. The counter is that the FDA does not require pre-market safety testing for cosmetics — the regulatory gap is not a defense, it is the explanation for how this danger went unaddressed for so long. Compliance with a regulatory floor does not excuse a company that knew its product was contaminated with a known carcinogen and chose silence.
Play 5: The quick settlement offer. In some cases, the defense or its representatives may reach out with a settlement offer early — before you have a lawyer, before your medical records are fully reviewed, before the full value of your claim is understood. A fast check arriving before the evidence is assembled is designed to close the case at the lowest possible number. The counter is simple: do not sign anything, do not accept anything, and do not give a recorded statement to anyone before you have spoken with an attorney who represents you, not the company.
The Statute of Limitations — Your Deadline
This is the single most urgent piece of information on this page. A talcum powder ovarian cancer lawsuit must be filed before a legal deadline known as the statute of limitations. These laws determine how long you have to take action after an ovarian cancer diagnosis or the loss of a loved one.
Ovarian cancer talc statutes of limitations typically range from 1 to 3 years, depending on the state. Once this deadline passes, you may lose your right to pursue compensation entirely — no matter how strong your case is, no matter how clear the causal connection, no matter how much the company knew. The court will not hear your claim.
But there is a critical exception that applies in most states: the discovery rule. For toxic tort claims involving latent diseases — diseases that take years or decades to appear after exposure — most states apply the discovery rule, which tolls (pauses) the limitations period until the plaintiff knew or reasonably should have known of the causal connection between the product and the injury. This means the clock may not start on the day you were exposed to talc. It may start on the day you were diagnosed with ovarian cancer — or even later, on the day you first learned that your talc use may have caused your cancer.
Because talc-related ovarian cancer can take decades to develop, you may still be able to file a claim even if your talc use occurred decades ago. The key date is often the diagnosis date, not the exposure date. But the exact rule depends on your state, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. You should never assume you have “plenty of time” without confirming the specific deadline for your jurisdiction.
Wrongful death claims follow each state’s wrongful death statute, with separate limitations periods and damage categories that differ from survival actions. If a loved one has passed away, the clock on a wrongful death claim may be shorter than the clock on a personal injury claim would have been. The $72 million wrongful death verdict in this litigation shows the potential of these claims, but the deadline is real and unforgiving.
This is why we say: the day you call is the day the clock starts working for you instead of against you. Not because calling tolls the statute — it does not — but because calling is what lets us determine your deadline, verify your eligibility, and file before the window closes. If you believe talcum powder contributed to your ovarian cancer, the safest move is to contact us as soon as possible so we can identify your specific deadline and work quickly to ensure your claim is submitted on time.
How a Talcum Powder Case Is Built
Here is the chronological walk of how a case like this is actually assembled, from the first phone call through resolution.
Step 1: Case Review. The first conversation is free. We ask about your history of talcum powder usage — which products, how often, how many years, and for what purpose. We ask about your ovarian cancer diagnosis — when it was made, what stage, what type, what treatment you have undergone. We ask whether anyone in your family has a history of ovarian cancer or BRCA mutations, because the defense will explore alternative causes and we need to know the answers before they do. If a loved one has passed away, we ask about their product use history, their diagnosis, and the date and cause of death. This conversation costs nothing and commits you to nothing.
Step 2: Evidence Collection. If we determine you may have a claim, we begin gathering evidence. This includes your medical records and pathology reports related to your cancer diagnosis. It includes any receipts, containers, or physical evidence of the talc-based products you used. It includes witness statements from family members and friends who can confirm your long-term product use. We have relationships with medical and scientific experts who can testify to the connection between your talcum powder use and ovarian cancer — experts whose methods the federal court has already ruled are reliable enough for a jury to hear.
Step 3: Filing. Depending on your situation, we can help you pursue the legal path that offers the strongest chance of compensation. You may qualify to file an individual talc ovarian cancer lawsuit in the MDL, or your case may proceed in your home state’s court. Your attorney will recommend the option that may offer you the greatest chance at compensation and file your claim before any legal deadlines. Because the MDL is consolidated in the District of New Jersey but each plaintiff’s substantive claims are governed by the tort law of their home state, the specific rules that apply to your case — your statute of limitations, your comparative fault rule, your damages framework — depend on where you live.
Step 4: Negotiation or Trial. Your lawyer will work to negotiate a settlement with the companies responsible for your illness, which may allow you to receive compensation without going to court. The court-ordered mediation in MDL-2738 creates a framework that may produce a global resolution. But if a fair settlement cannot be reached, we are prepared to present your case in court and fight for compensation from a talc ovarian cancer verdict. The bellwether trials — including the $40 million California verdict in December 2025 — demonstrate that juries are willing to hold J&J accountable when the evidence is presented.
Who Can File a Talcum Powder Ovarian Cancer Lawsuit?
Eligibility is determined by your history of talcum powder use and your resulting diagnosis. You may qualify if you:
- Used talc-based products like Johnson’s Baby Powder, Shower to Shower, Cashmere Bouquet, Avon talc products, or similar products for feminine hygiene or body powder use
- Were later diagnosed with ovarian cancer or mesothelioma
- Used the products regularly for a period of years (duration and frequency matter for exposure quantification)
If a loved one passed away from ovarian cancer linked to talcum powder use, you may be able to file a wrongful death claim on their behalf. The family of the woman in the $72 million Fox verdict did exactly this — and the jury awarded $10 million in actual damages and $62 million in punitive damages after finding J&J liable for fraud, negligence, and conspiracy.
If your loved one has passed away, do not assume it is too late. Wrongful death claims may still be viable, and family members can act on behalf of the estate. But the statute of limitations for wrongful death is often shorter than for personal injury, so time is even more critical.
The Medicine: What Ovarian Cancer From Talc Looks Like and What It Costs
Ovarian cancer linked to talcum powder is treated the same way as other forms of ovarian cancer — the treatment does not change based on the cause. But the cost is staggering, and the prognosis is often difficult because of the latency and the late stage at which many of these cancers are diagnosed.
Surgery is typically the first step: removal of the ovaries, fallopian tubes, uterus, and nearby tissue where cancer may have spread. For many women, this means a complete hysterectomy with bilateral salpingo-oophorectomy, and in advanced cases, debulking surgery to remove as much tumor tissue as possible.
Chemotherapy is usually given after surgery to destroy remaining cancer cells, or sometimes before surgery to shrink tumors. The regimens are grueling — multiple cycles over months, with side effects that include nausea, hair loss, fatigue, neuropathy, and immune suppression.
Immunotherapy or targeted therapy uses medications that attack cancer cells specifically. Hormone therapy blocks hormones in cancer cells to prevent them from growing. These treatments may extend survival but come with their own side effects and costs.
Treatment expenses often exceed $200,000 a year, according to the American Journal of Obstetrics and Gynecology. For a woman diagnosed at stage III or IV — which is common because the symptoms are vague and the disease is frequently caught late — the treatment course can span years, with recurrence being a persistent threat. The financial burden compounds: medical bills, lost wages from inability to work, diminished earning capacity, and the cost of ongoing monitoring for recurrence.
It is also important to get a second opinion if you are diagnosed with ovarian cancer. Mesothelioma is another asbestos-caused cancer that can sometimes be mistaken for ovarian cancer — and if your cancer is mesothelioma rather than ovarian cancer, the causation story and the legal path may differ. A precise pathology diagnosis matters both for your treatment and for your case.
The Bankruptcy Shell Game — Why It Matters to Your Case
Johnson & Johnson has attempted three times to use a corporate restructuring maneuver called the “Texas two-step” to push talc liabilities into a subsidiary entity and file that entity for bankruptcy. The strategy is designed to force all pending claims into a single bankruptcy proceeding where a judge can approve a global settlement — potentially for less than the cases are worth in the tort system.
Each attempt has failed:
- 2021: J&J’s first attempt, shifting talc liabilities to a subsidiary and filing for Chapter 11.
- 2023: Federal courts blocked both of J&J’s first two bankruptcy attempts, ruling the company was not in financial distress — J&J is one of the most valuable companies in the world, with its stock trading normally and its other businesses fully operational.
- 2024: J&J’s subsidiary Red River Talc LLC filed for bankruptcy a third time, offering an $8 billion settlement in hopes of securing court approval.
- 2025: A U.S. bankruptcy judge rejected the proposed $8 billion settlement, citing concerns about the amount not being enough and problems with the voting process.
Three times the company tried to wall these cases off inside a bankruptcy it created on purpose. Three times a court threw it out. The cases are back in the regular court system, where juries can hear the evidence and return verdicts that reflect the actual harm — not a negotiated ceiling designed to cap the company’s exposure.
Why does this matter to you? Because every time J&J files a bankruptcy, it creates uncertainty and delay. Claims may be paused. Settlement negotiations may be disrupted. And the company uses the bankruptcy filing to argue that claimants should accept less because the alternative is waiting years for a bankruptcy resolution that may never come. Knowing that these attempts have failed — three times — means you do not have to accept the premise that bankruptcy is your only option. The tort system is open. The bellwether trials are producing verdicts. The court-ordered mediation is ongoing.
Who We Are
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes cases involving catastrophic injury, toxic exposure, and wrongful death. We work on contingency, which means we do not get paid unless we win your case. The first conversation is free, and it costs nothing to find out whether you have a claim.
Ralph Manginello is our Managing Partner. He has been a licensed Texas attorney since November 6, 1998 — 27+ years in courtrooms, including federal court. He is admitted to the U.S. District Court for the Southern District of Texas. Before he was a lawyer, he was a journalist, which means he learned early that the truth is something you find, not something you manufacture. He approaches every case the way a reporter approaches a story: follow the documents, follow the evidence, and let the facts lead where they lead. He is a member of the Texas Trial Lawyers Association and the Houston Bar Association, and he has led the active $10M+ hazing lawsuit against Pi Kappa Phi at the University of Houston — a case that shows exactly the kind of institutional accountability he pursues.
Lupe Peña is our Associate Attorney. He has been licensed since December 6, 2012 — 13+ years of practice, admitted to the U.S. District Court for the Southern District of Texas. Before he joined this firm, Lupe spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims exactly like yours. He knows how the other side prices a claim, how they choose their IME doctors, how they structure surveillance, and how they use delay as a weapon. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full client consultations in Spanish without an interpreter.
You can learn more about our practice areas — including our work on toxic tort claims — on our site. For a deeper look at how we think about case value, Ralph has discussed the question on video: how much is my personal injury case worth. And if you want to understand exactly how our fee structure works — how contingency works — we have explained that too: how do contingency fees work.
Frequently Asked Questions
Does asbestos cause ovarian cancer?
Yes. The International Agency for Research on Cancer — the world’s leading cancer authority — classifies asbestos as a Group 1 confirmed human carcinogen and specifically recognizes it as a cause of ovarian cancer. Studies have found higher ovarian cancer rates in women exposed to asbestos, including those who used talc products contaminated with asbestos. Women who used talcum powder in the genital area were 33% more likely to develop ovarian cancer, according to the National Library of Medicine. In January 2026, a federal judge ruled that expert witnesses can testify about the link between genital talcum powder use and ovarian cancer, finding that they used reliable scientific methods to support their opinions.
How does talcum powder cause ovarian cancer?
When talcum powder is used in the genital area, talc and asbestos particles can travel through the reproductive tract and reach the ovaries. These particles lodge in ovarian tissue and trigger chronic inflammation over time. Because the body cannot clear asbestos fibers, the inflammation persists for decades, increasing the risk of abnormal cell growth that becomes ovarian cancer. Talc particles have been identified in ovarian tumors during scientific examinations. The disease generally forms slowly over many years — which is why women often report using talcum powder regularly for decades before their diagnosis.
What are the symptoms of ovarian cancer from talc?
Ovarian cancer linked to talc use causes the same symptoms as ovarian cancer from any other cause. These may include abdominal bloating, changes in bowel habits, feeling full quickly, pelvic pain, unexplained weight loss, back pain, a frequent need to urinate, and fatigue. Because these symptoms are often vague and easy to overlook, ovarian cancer is frequently diagnosed in later stages. If you have a history of talc use and are experiencing any of these symptoms, get medical attention and mention your talc use history to your doctor. It is also important to get a second opinion if you are diagnosed — mesothelioma is another asbestos-caused cancer that can sometimes be mistaken for ovarian cancer.
How long do I have to file a talc powder ovarian cancer lawsuit?
You typically have 1 to 3 years from the date of your diagnosis — or the death of a loved one — to file a talc powder ovarian cancer lawsuit. The exact deadline depends on your state’s statute of limitations. However, most states apply the discovery rule to toxic tort claims involving latent diseases, meaning the clock may not start until you knew or reasonably should have known that your cancer was connected to your talc use. Because the rules vary by state and some states impose outer deadlines (statutes of repose), you should confirm the specific deadline for your jurisdiction with an attorney as soon as possible.
Is there a talcum powder ovarian cancer class action lawsuit?
The ovarian cancer talcum powder lawsuits are being handled as part of a federal multidistrict litigation (MDL-2738) in the District of New Jersey. This is similar to a class action in that thousands of similar claims against Johnson & Johnson are grouped together for pretrial efficiency, but each woman keeps her own individual claim and pursues her own compensation. Today, the MDL includes more than 68,435 women who say they developed ovarian cancer after talc use. Federal judges have ordered both sides into court-supervised mediation, pushing toward a potential negotiated global settlement.
Have there been any talcum powder ovarian cancer settlements?
Yes. In 2020, J&J reached its first major talc-related settlement, paying over $100 million to resolve more than 1,000 mesothelioma and ovarian cancer lawsuits. In 2024, J&J agreed to pay $700 million to settle claims from 42 states and Washington, D.C. over misleading marketing. In 2018, a jury ordered J&J to pay $4.69 billion to 22 talc ovarian cancer victims — an award later reduced to $2.12 billion but upheld through the U.S. Supreme Court’s denial of certiorari. Individual verdicts have ranged from $40 million to $110 million. J&J has reportedly set aside $11 billion to resolve all talc claims.
How much do talcum powder ovarian cancer lawyers charge?
At our firm, there are no upfront costs or hourly fees to work with our talcum powder ovarian cancer lawyers. We handle cases on a contingency-fee basis, which means you pay nothing unless your case results in compensation. Our fee is 33.33% of the recovery if the case settles before trial, and 40% if the case goes to trial. The first consultation is free. You can reach us at 1-888-ATTY-911 (1-888-288-9911), 24 hours a day, 7 days a week. You will speak to a live person, not an answering service.
I used talc products decades ago — is it too late to file?
It may not be. Because ovarian cancer from talc exposure can take decades to develop, most states apply the discovery rule, which means the statute of limitations may not start until you were diagnosed — or until you reasonably should have known your cancer was connected to your talc use. A diagnosis you received recently may be the day your rights began, not the day they ended. However, some states have outer deadlines (statutes of repose) that can cut off a claim regardless of discovery. The only way to know for certain whether your claim is still alive is to have an attorney check the specific deadline for your state. Do not assume it is too late without confirming.
My mother passed away from ovarian cancer. She used baby powder for years. Can our family still file a claim?
Possibly, yes. If your mother used talc-based products and was diagnosed with ovarian cancer, her estate or family members may be able to file a wrongful death claim. Wrongful death claims have their own statute of limitations — often shorter than personal injury claims — so time is critical. The $72 million wrongful death verdict in the talc litigation shows the potential of these claims: a jury awarded $10 million in actual damages and $62 million in punitive damages to the family of a woman who used J&J’s baby powder and Shower to Shower for more than 35 years. Family members can act on behalf of their loved one’s estate, but the deadline is real and unforgiving.
How to Reach Us
If you or a loved one was diagnosed with ovarian cancer after using talc-based products, compensation may be available. Thousands of women have come forward. Billions of dollars have already been awarded. The science has been admitted in court. The corporate concealment has been exposed. The bankruptcy attempts have failed. The cases are proceeding.
The call is free. The consultation is free. There is no fee unless we win your case. You will speak to a live person, 24 hours a day, 7 days a week — not an answering service, not a call center, a person.
1-888-ATTY-911 (1-888-288-9911)
Or contact us online — we will get back to you.
Hablamos Español. Lupe Peña conducts full consultations in Spanish without an interpreter. If your family communicates in Spanish, we will speak to you in the language you think in.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential. We serve clients in all 50 states, working with local counsel where required.
The day you call is the day the evidence gets frozen, the deadline gets identified, and the fight begins. Everything before that call is the clock working against you. Everything after it is the clock working for you.